Clinical Trial Update: Momelotinib During and After HCT in Myelofibrosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating momelotinib during and after hematopoietic cell transplantation in patients with myelofibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Momelotinib (momelotinib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Myelofibrosis, Hematopoietic Cell Transplantation (HCT) | Phase 1 | Status: RECRUITING